|
|
|
| Discussion on prescription theory of ancient classical prescription of Kaixin Powder and its related prescriptions |
| YIN Junmei1 WANG Cai1 DING Kan2 GAO Ya2 |
1.Research Institute of Traditional Chinese Medicine, China Resources Sanjiu Medical & Pharmaceutical Co.,Ltd, Guangdong Province, Shenzhen 518000, China;
2.Institute of Chinese Medical History and Literature, China Academy of Chinese Medical Sciences, Beijing 100700, China |
|
|
|
|
Abstract Kaixin Powder is in the first batch of ancient classical prescription published by National Administration of Traditional Chinese Medicine. Kaixin Powder is a commonly used prescription for traditional Chinese Medicine clinial treatment of “forgettery”. In the process of application by later clinical practitioners, related prescriptions had been evolved. Compared with Kaixin Powder, the theory of related prescriptions are both “righteous” and “innovative”. The article inspects the name of Kaixin Powder and the source of it, discusses the feature of Kaixin Powder and its related prescriptions, and clarifies the change of the treatment scope. As a result, Kaixin Powder comes from the book of Jiyan Fang wrote by an ancient doctor named Yao Sengyuan. It is believed that the name of Kaixin Powder indicates the functional regulation of opening the heart and regulating the kidney. In the process of spreading, this formula has derived seven main types of prescriptions, including Dingzhi Pills, Lingren Buwang Fang, Yuanzhi Powder, Xiaodingzhi Pills, Yuanzhi Pills, Jiawei Dingzhi Pills, and Changpu Yizhi Pills. Kaixin Powder and its related prescriptions follow the theory of compatibility of sweet, bitter, and pungent, and determine the dosage of the main medicine according to the characteristics of the syndrome, and the method of administration according to the characteristics of the dosage form. According to the theory of this group of prescription, the main treatment syndromes of Kaixin Powder and its related prescriptions have gone through a process from simple “forgettery” to abnormal mental state, and then to psychosomatic diseases, which has an enlightening effect on exploring and expanding the clinical application scope of Kaixin Powder.
|
|
|
|
|
|
[1] 安宏，刘谦，王柳青，等.论中医药传统知识保护对解决中医药“不传”之痛的意义[J].中国医药导报，2022，19（25）：111-114，123.
[2] 国家中医药管理局.古代经典名方目录（第一批）[EB/OL].（2018-04-13）[2020-07-30]. http：//kjs.satcm.gov.cn/zhen- gcewenjian/2020-05-26/15394.html.
[3] 国家药品监督管理局.关于发布古代经典名方中药复方制剂简化注册审批管理规定的公告（2018年第27号）[EB/OL].（2018-05-29）[2020-07-30].https：//www.nmpa.gov.cn/xxgk/ggtg/qtggtg/20180601163901361.html.
[4] 国家中医药管理局.国家中医药管理局办公室 国家药品监督管理局综合和规划财务司关于发布《古代经典名方关键信息表（25首方剂）》的通知[EB/OL].（2022-09-07）[2023-03-10]. http：//www.natcm.gov.cn/kejisi/gongzuodongtai/2022-09-27/27803.html.
[5] 何永，马君，何敬华.黄帝内经素问[M].北京：中国中医药出版社，2006.
[6] 张春林.苏轼全集：上[M].北京：中国文史出版社，1999：394.
[7] 丹波康赖.医心方[M].沈阳：辽宁科学技术出版社，1996.
[8] 孙思邈.备急千金要方[M].北京：中医古籍出版社，2022.
[9] 顾观光，杨鹏举.神农本草经[M].北京：学苑出版社，2007：31-72.
[10] 张林，曾凤.《千金要方》开心散剂量的文献考证[J].北京中医药大学学报，2020，43（8）：641-644.
[11] 尚炳娴，戴子琦，吴倩文，等.经典名方开心散的处方与本草考证[J].西北药学杂志，2022，37（3）：12-19.
[12] 朱方丽.基于数据挖掘的痴呆证型分布特点及用药规律研究[D].沈阳：辽宁中医药大学，2022.
[13] 方有执.伤寒论条辨[M].太原：山西科学技术出版社，2009：80.
[14] 傅延龄，陈传蓉，倪胜楼，等.论方寸匕、钱匕及其量值[J].中医杂志，2014，55（7）：624-625.
[15] 赵佶.圣济总录[M].北京：中国中医药出版社，2018.
[16] 易腾达，李玉丽，牛林强，等.经典名方开心散及类方的古代文献考证[J].中国实验方剂学杂志，2021，27（5）：8-15.
[17] 无名氏，魏淳.明目至宝[M].北京：人民卫生出版社，1992.
[18] 薛铠，薛己.保婴撮要[M].北京：中国中医药出版社，2016：55.
[19] 楼英.医学纲目[M].北京：学苑出版社，2021：356.
[20] 吴昆.黄帝内经素问吴注[M].北京：学苑出版社，2001：113.
[21] 安宏，秦培洁，王柳青，等.辨“手诊”“手相”[J].中国中医基础医学杂志，2021，27（10）：1578-1580，1674.
[22] 郭会军，曹柏龙.医道中和——国医大师孙光荣临证心法要诀[J].中国中医药现代远程教育，2019，17（4）：156.
[23] 陈丽娟，颜乾麟，颜新.颜德馨心系疾病用药心法[J].中医杂志，2014，55（24）：2081-2083.
[24] 安宏，徐世杰，高雅.王好古火热辨治理论与应用探析[J].中国中医基础医学杂志，2023，29（1）：36-38.
[25] 殷俊梅，王偲，丁侃，等.经典名方开心散及其类中医文献研究概述[J].中国医药导刊，2023，25（4）：416-419. |
|
|
|
